One Day Conference : 25 October 2007 |
| 07.00 |
Day 1: Registration Opens 7.00am |
Session 1 : Product Commercialisation and Launch |
| 08.10 |
Chairperson TBC
|
| 08.15 |
Can we get the unholy alliance between Research & Development and Marketing right?
Malcolm Allison, Head of New Products, Actelion
|
| 08.45 |
Create a powerful value proposition for our drugs so they make a bigger impact on launch
Harris Kaplan, CEO, Healogix |
| 09.15 |
Build success through sustainable partnerships
Keith Allan, Head of Global Advocacy, Novartis
|
| 09.45 |
Pricing considerations when launching a drug
Philip J Young, President and CEO, Osteologix
|
| 10.15 |
Coffee Break – 30 minutes |
Session 2 : Lifecycle Management |
| 10.45 |
Combination Products in the context of lifecycle management
Josep Lamarca, Senior Director, Corporate Licensing, Almirall
|
| 11.15 |
Sildenafil: Extending the indication from erectile dysfunction to pulmonary hypertension
Colin Ewan, Executive Director and Development Team Leader, Pfizer
|
| 11.45 |
Defend your brand and sales of your drug against generic competition: line extensions and reformulation
Nicolas Nemery, Senior VP, Commercial Operations, Lifecycle Pharma
|
| 12.15 |
The Changing face of product lifecycle management
Allistair Booth, Partner, Fasken Martineau Stringer Saul
|
12.45 |
Lunch – 1 Hour 15 Mins |
| 14.00 |
1. Workshop: Excellence in Closed-Loop Marketing to Increase Sales and Shorten Time to Market
Anders Sølgaard, Creative Director,, Agnitio
|
2. Workshop: Increase Market Share through Product Design – Building Global Bran
Deborah J Taylor, Market Development Manager – Europe, Colorcon
Dawn Bock, Marketing Development Manager – North America, Colorcon
|
3. Workshop: Reducing Costs through a Global Delivery Model - Roadmap to Global Sourcing of Marketing Services
Sanjay Parikh, Director Indegene
|
|
Session 3 : Portfolio Management |
| 15.30 |
Prioritising portfolio projects using effective value-based management processes
Ward Peterson, PhD, VP of Discovery, Inspire Pharmaceuticals |
| 16.00 |
Ensure value across the product development process
Pasi Piitulainen, Director, Business Science Affairs, Actelion Pharmaceuticals
|
| 16.30 |
Coffee Break – 30 minutes |
| 17.00 |
Examine the current status and future of intellectual property rights trends to optimise the value on your patent portfolio
Marianne Johansen, Managing Director, Albihns A/S
|
| 17.30 |
Generate insights beyond traditional portfolio management
Joshi Venugopal, PhD, Global Portfolio Manager, Strategy Planning & Portfolio Management Group, Novartis |
| 18.00 |
Learn to integrate a sparse pipeline and limited resources with your company’s vision
Manos Papadakis, Portfolio & Planning Manager, GlaxoSmithKline
|
| 18.30 |
Play your cards right: How to use biomarkers for more effective marketing campaigns
Malcolm Allison, Head of New Products, Actelion |
| 19.00 |
Conference networking reception |
| 20.00 |
End of Early Commercialisation, Lifecycle and Portfolio Management Conference |
